查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1736526

全球豬瘟疫苗市場規模（依產品、應用、區域範圍及預測）

Global Swine Fever Vaccine Market Size By Product, By Application, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 | 商品交期: 2-3個工作天內

價格
簡介目錄

豬瘟疫苗市場規模及預測

2024 年豬瘟疫苗市場規模為 16 億美元，預計到 2032 年將達到 26 億美元，2026 年至 2032 年的複合年成長率為 5.1%。

推動全球豬瘟疫苗市場的因素

豬瘟疫苗市場的市場促進因素可能受到多種因素的影響，其中包括：

生豬數量不斷增加：隨著全球生豬數量持續成長，尤其是在亞洲和拉丁美洲等地區，對有效疫苗預防豬瘟等疾病的需求也日益增加。

政府措施與法規：為了控制和遏制豬流感疫情，政府和監管機構經常強制推行疫苗接種計畫。豬流感疫苗市場受立法和政策驅動。

對疾病爆發的擔憂日益加劇：豬瘟爆發可能對養豬業帶來重大經濟損失。這些傳染病的重要性正日益得到農民和其他相關人員的廣泛認可，推動了對疫苗接種作為預防策略的需求。

技術發展：開發更安全、更有效的免疫接種是技術進步的一個方面，有助於疫苗產業擴大市場。這包括佐劑技術、疫苗配方和遞送技術的進步。

加強教育和意識：市場需求的驅動力源自於養豬戶對疫苗接種和疾病預防價值的認知不斷加深。進行宣傳教育宣傳活動，強調疫苗接種在疾病防治中的作用至關重要。

養豬業全球化：養豬業跨國家和地區互聯互通，因此疾病爆發可能造成重大影響。強而有力的疫苗接種計畫至關重要，而全球化這一因素正在幫助擴大市場。

研發投入：生技和製藥公司的研發投入將推動新型、更優的豬瘟疫苗的開發。這些發展將推動競爭和商業性擴張。

重視動物健康和福利：畜牧業更重視動物健康和福利標準，鼓勵接種疫苗以預防豬瘟等疾病，有助於擴大市場。

限制全球豬瘟疫苗市場的因素

豬瘟疫苗市場可能面臨多種限制與挑戰，包括：

監管挑戰：由於嚴格的安全標準和法規，獲得豬瘟疫苗的核准成本高且耗時。這項流程可能會延遲新產品的上市，並為新的競爭對手設定進入障礙。

知識和教育有限：在某些地區，農民和牲畜飼養者可能尚未充分認知到豬瘟疫苗的益處。這可能導致疫苗接種覆蓋率低和需求減少，尤其是在豬流感發病率較低的地區。

疫苗接種計畫成本高昂：在大型豬群參與綜合疫苗接種計畫時，農民和政府可能會承擔巨額成本。疫苗的採購、管理和安排接種費用可能是一個重大障礙，尤其對於資源匱乏地區的小型農場而言。

物流挑戰：維護疫苗儲存和分發的低溫運輸是高效率向偏遠農村地區分發疫苗的物流挑戰之一。此類行政障礙可能會限制所有養豬戶獲得疫苗，這可能會影響市場滲透率。

有效性和安全性問題：對於製造商而言，豬流感疫苗的有效性和安全性至關重要。疫苗對不同病毒株的有效性、可能的副作用以及長期免疫力等問題會影響生產者對疫苗接種計劃的信心和採用。

競爭激烈的市場環境：價格競爭和產品差異化是市場上存在多家疫苗生產商和產品可能帶來的競爭壓力的兩個例子。競爭格局可能會限制個別疫苗供應商的擴張，並影響市場的整體動態。

貿易壁壘和出口問題：豬瘟疫情可能會限制來自疫區的豬產品的貿易，這可能會間接影響對豬瘟疫苗的需求，因為生產商對市場進入和出口潛力持懷疑態度，並且不願意投資疫苗接種計劃。

目錄

第1章 豬瘟疫苗全球市場介紹

  • 市場定義
  • 市場區隔
  • 調查時間表
  • 先決條件
  • 限制

第 2 章 已驗證的市場研究調查方法

  • 資料探勘
  • 數據三角測量
  • 自下而上的方法
  • 自上而下的方法
  • 調查流程
  • 業界專家的重要見解
  • 資料來源

第3章執行摘要

  • 市場概覽
  • 生態測繪
  • 絕對的商機
  • 市場吸引力
  • 全球豬瘟疫苗市場區域分析
  • 全球豬瘟疫苗市場（按產品分類）（百萬美元）
  • 全球豬瘟疫苗市場應用（百萬美元）
  • 未來市場機會
  • 世界市場結構
  • 產品生命線

第4章 全球豬瘟疫苗市場展望

  • 豬瘟疫苗的全球演變
  • 驅動程式
    • 促進要素1
    • 促進要素2
  • 限制因素
    • 約束因素 1
    • 約束因素 2
  • 機會
    • 機會1
    • 機會2
  • 波特五力模型
  • 價值鏈分析
  • 定價分析
  • 宏觀經濟分析

第5章全球豬瘟疫苗市場（依產品）

  • 概述
  • 組織培養衍生
  • 細胞株來源

6. 全球豬瘟疫苗市場（依應用）

  • 概述
  • 政府競標
  • 市場銷售

7. 全球豬瘟疫苗市場（按地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 中東和非洲
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 南非
    • 其他中東和非洲地區

第8章全球豬瘟疫苗市場競爭格局

  • 概述
  • 各公司市場排名
  • 公司地理分佈
  • 公司產業佈局
  • ACE矩陣

第9章 公司簡介

  • Ceva
  • Boehringer Ingelheim International
  • Bioveta
  • Panav BIoTech
  • WINSUN
  • Merial
  • CAHIC
  • Chopper Biology
  • MSD Animal Health
  • ChengDu Tecbond

第10章 已驗證的市場情報

  • 關於已驗證的市場情報
  • 動態資料視覺化
簡介目錄
Product Code: 37468

Swine Fever Vaccine Market Size And Forecast

Swine Fever Vaccine Market size was valued at USD 1.6 Billion in 2024 and is projected to reach USD 2.6 Billion by 2032, growing at a CAGR of 5.1% during the forecast period 2026-2032.

Global Swine Fever Vaccine Market Drivers

The market drivers for the Swine Fever Vaccine Market can be influenced by various factors. These may include:

Growing Swine Population: There is an increasing need for efficient vaccines to prevent diseases like swine fever as the world's pig population continues to grow, particularly in areas like Asia and Latin America.

Government Initiatives and Regulations: To manage and stop swine flu outbreaks, governments and regulatory agencies frequently require vaccination programmes. The market for swine flu vaccinations is driven by laws and policies that are supportive.

Growing Fears Regarding Disease Outbreaks: The swine sector may suffer large financial losses as a result of swine fever outbreaks. The significance of these epidemics is becoming more widely recognised among farmers and other stakeholders, which is driving up demand for vaccinations as a preventive strategy.

Technological developments: The creation of safer and more effective vaccinations is one aspect of the vaccine industry's technological advancements that support market expansion. This covers developments in adjuvant technology, vaccination formulation, and delivery techniques.

Growing Education and Awareness: Market demand is driven by swine farmers' growing understanding of the value of immunisation and illness prevention. Campaigns for education that emphasise the advantages of vaccinations for the prevention and control of disease are important.

Globalisation of the Swine Industry: Disease outbreaks can have a significant impact due to the interconnectedness of the swine industry across nations and regions. Strong immunisation programmes are required, and this globalisation element propels market expansion.

Research and Development Investments: New and better swine fever vaccines are developed as a result of research and development investments made by biotech and pharmaceutical companies. Competitiveness and commercial expansion are fueled by these developments.

Focus on Animal Health and Welfare: As the livestock business places a greater emphasis on animal health and welfare standards, vaccination use to ward off diseases like swine fever is encouraged, which propels market expansion.

Global Swine Fever Vaccine Market Restraints

Several factors can act as restraints or challenges for the Swine Fever Vaccine Market . These may include:

Regulatory Challenges: Due to strict safety standards and regulatory regulations, obtaining regulatory approval for swine fever vaccines can be costly and time-consuming. This procedure may delay the release of new products and serve as a barrier to entry for new competitors.

Limited Knowledge and Education: In certain areas, farmers and livestock owners might not be fully informed of the advantages of swine fever vaccine. This may result in slower adoption rates and decreased demand for vaccinations, especially in regions with fewer swine flu outbreaks.

High Expense of Vaccination Programmes: Farmers and governments may incur significant expenses when putting big swine populations through comprehensive vaccination programmes. Vaccine procurement, administration, and schedule management costs can be a major barrier, particularly for small-scale farms in areas with scarce resources.

Logistical Difficulties: Maintaining the cold chain for vaccine storage and delivery is one logistical problem in the efficient distribution of vaccinations to remote or rural locations. These administrative obstacles may limit vaccination accessibility for all swine farmers, which may have an effect on market penetration.

Efficacy and Safety Concerns: For manufacturers, the effectiveness and safety of swine flu vaccinations are paramount. The effectiveness of vaccines against various virus strains, possible side effects, and long-term immunity are some of the issues that can affect producer trust in vaccination programmes and adoption rates.

Competitive Market Environment: Price wars and product differentiation are two examples of the competitive pressures that can arise from the existence of several vaccine producers and products on the market. The competitive landscape could limit the expansion of individual vaccine suppliers and affect the general dynamics of the market.

Trade Barriers and Export Issues: Outbreaks of swine fever may result in trade restrictions on pig products originating from impacted areas. Because producers would be hesitant to invest in immunisation programmes due to doubts about market access and export potential, this could have an indirect effect on the demand for swine fever vaccinations.

Global Swine Fever Vaccine Market Segmentation Analysis

The Global Swine Fever Vaccine Market is segmented on the basis of Product, Application, and Geography.

Swine Fever Vaccine Market, By Product

  • Tissue Culture Origin
  • Cell Line Origin

Based on Product, The market is segmented into Tissue Culture Origin and Cell Line Origin. The Tissue Culture Origin segment is anticipated to dominate the Global Swine Fever Vaccine Market. The US biopharmaceutical industries heavily rely on cell culture for tissue culture, drug research, and vaccine manufacture. The segment is expected to develop significantly since tissue culture is vital in the traditional Swine Fever Vaccine.

Swine Fever Vaccine Market, By Application

  • Government Tender
  • Market Sales

Based on Application, The market is segmented into Government Tender and Market Sales. The Government Tender segment is anticipated to dominate the Global Swine Fever Vaccine Market. Due to the government's intense attention on preventing the spread of classical swine disease, a government tender for the sale of the vaccine is set.

Swine Fever Vaccine Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Geography, the Global Swine Fever Vaccine Market is classified into North America, Europe, Asia Pacific, And Rest of the world. North America will hold the largest Global Swine Fever Vaccine Market. The US supplied the largest market share in the North American market for classical Swine Fever Vaccines throughout the forecast period. The region's market for traditional Swine Fever Vaccines is expanding due to several factors, including the region's highly developed healthcare system and the significant investment in R&D to create innovative vaccines for various illnesses.

Key Players

  • The major players in the Swine Fever Vaccine Market are:
  • WINSUN
  • Merial
  • CAHIC
  • Chopper Biology
  • MSD Animal Health
  • ChengDu Tecbond
  • Ceva
  • Veterinary
  • Ringpu Biology
  • Jinyu Bio-Technology
  • Institute Pasteur
  • TecOn
  • Panav Biotech
  • Boehringer Ingelheim International

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL SWINE FEVER VACCINE MARKET

  • 1.1 Market Definition
  • 1.2 Market Segmentation
  • 1.3 Research Timelines
  • 1.4 Assumptions
  • 1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 2.1 Data Mining
  • 2.2 Data Triangulation
  • 2.3 Bottom-Up Approach
  • 2.4 Top-Down Approach
  • 2.5 Research Flow
  • 2.6 Key Insights from Industry Experts
  • 2.7 Data Sources

3 EXECUTIVE SUMMARY

  • 3.1 Market Overview
  • 3.2 Ecology Mapping
  • 3.3 Absolute Market Opportunity
  • 3.4 Market Attractiveness
  • 3.5 Global Swine Fever Vaccine Market Geographical Analysis (CAGR %)
  • 3.6 Global Swine Fever Vaccine Market, By Product (USD Million)
  • 3.7 Global Swine Fever Vaccine Market, By Application (USD Million)
  • 3.8 Future Market Opportunities
  • 3.9 Global Market Split
  • 3.10 Product Life Line

4 GLOBAL SWINE FEVER VACCINE MARKET OUTLOOK

  • 4.1 Global Swine Fever Vaccine Evolution
  • 4.2 Drivers
    • 4.2.1 Driver1
    • 4.2.2 Driver 2
  • 4.3 Restraints
    • 4.3.1 Restraint1
    • 4.3.2 Restraint 2
  • 4.4 Opportunities
    • 4.4.1 Opportunity1
    • 4.4.2 Opportunity 2
  • 4.5 Porters Five Force Model
  • 4.6 Value Chain Analysis
  • 4.7 Pricing Analysis
  • 4.8 Macroeconomic Analysis

5 GLOBAL SWINE FEVER VACCINE MARKET, BY PRODUCT

  • 5.1 Overview
  • 5.2 Tissue Culture Origin
  • 5.3 Cell Line Origin

6 GLOBAL SWINE FEVER VACCINE MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Government Tender
  • 6.3 Market Sales

7 GLOBAL SWINE FEVER VACCINE MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Argentina
    • 7.5.3 Rest of Latin America
  • 7.6 Middle-East and Africa
    • 7.6.1 UAE
    • 7.6.2 Saudi Arabia
    • 7.6.3 South Africa
    • 7.6.4 Rest of Middle-East and Africa

8 GLOBAL SWINE FEVER VACCINE MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Developments
  • 8.4 Company Regional Footprint
  • 8.5 Company Industry Footprint
  • 8.6 ACE Matrix

9 COMPANY PROFILES

  • 9.1 Ceva
    • 9.1.1 Company Overview
    • 9.1.2 Company Insights
    • 9.1.3 Product Benchmarking
    • 9.1.4 Key Developments
    • 9.1.5 Winning Imperatives
    • 9.1.6 Current Focus & Strategies
    • 9.1.7 Threat from Competition
    • 9.1.8 SWOT Analysis
  • 9.2 Boehringer Ingelheim International
    • 9.2.1 Company Overview
    • 9.2.2 Company Insights
    • 9.2.3 Product Benchmarking
    • 9.2.4 Key Developments
    • 9.2.5 Winning Imperatives
    • 9.2.6 Current Focus & Strategies
    • 9.2.7 Threat from Competition
    • 9.2.8 SWOT Analysis
  • 9.3 Bioveta
    • 9.3.1 Company Overview
    • 9.3.2 Company Insights
    • 9.3.3 Product Benchmarking
    • 9.3.4 Key Developments
    • 9.3.5 Winning Imperatives
    • 9.3.6 Current Focus & Strategies
    • 9.3.7 Threat from Competition
    • 9.3.8 SWOT Analysis
  • 9.4 Panav Biotech
    • 9.4.1 Company Overview
    • 9.4.2 Company Insights
    • 9.4.3 Product Benchmarking
    • 9.4.4 Key Developments
    • 9.4.5 Winning Imperatives
    • 9.4.6 Current Focus & Strategies
    • 9.4.7 Threat from Competition
    • 9.4.8 SWOT Analysis
  • 9.5 WINSUN
    • 9.5.1 Company Overview
    • 9.5.2 Company Insights
    • 9.5.3 Product Benchmarking
    • 9.5.4 Key Developments
    • 9.5.5 Winning Imperatives
    • 9.5.6 Current Focus & Strategies
    • 9.5.7 Threat from Competition
    • 9.5.8 SWOT Analysis
  • 9.6 Merial
    • 9.6.1 Company Overview
    • 9.6.2 Company Insights
    • 9.6.3 Product Benchmarking
    • 9.6.4 Key Developments
    • 9.6.5 Winning Imperatives
    • 9.6.6 Current Focus & Strategies
    • 9.6.7 Threat from Competition
    • 9.6.8 SWOT Analysis
  • 9.7 CAHIC
    • 9.7.1 Company Overview
    • 9.7.2 Company Insights
    • 9.7.3 Product Benchmarking
    • 9.7.4 Key Developments
    • 9.7.5 Winning Imperatives
    • 9.7.6 Current Focus & Strategies
    • 9.7.7 Threat from Competition
    • 9.7.8 SWOT Analysis
  • 9.8 Chopper Biology
    • 9.8.1 Company Overview
    • 9.8.2 Company Insights
    • 9.8.3 Product Benchmarking
    • 9.8.4 Key Developments
    • 9.8.5 Winning Imperatives
    • 9.8.6 Current Focus & Strategies
    • 9.8.7 Threat from Competition
    • 9.8.8 SWOT Analysis
  • 9.9 MSD Animal Health
    • 9.9.1 Company Overview
    • 9.9.2 Company Insights
    • 9.9.3 Product Benchmarking
    • 9.9.4 Key Developments
    • 9.9.5 Winning Imperatives
    • 9.9.6 Current Focus & Strategies
    • 9.9.7 Threat from Competition
    • 9.9.8 SWOT Analysis
  • 9.10 ChengDu Tecbond
    • 9.10.1 Company Overview
    • 9.10.2 Company Insights
    • 9.10.3 Product Benchmarking
    • 9.10.4 Key Developments
    • 9.10.5 Winning Imperatives
    • 9.10.6 Current Focus & Strategies
    • 9.10.7 Threat from Competition
    • 9.10.8 SWOT Analysis

10. VERIFIED MARKET INTELLIGENCE

  • 10.1 About Verified Market Intelligence
  • 10.2 Dynamic Data Visualization